205 related articles for article (PubMed ID: 2542796)
1. A potential basis for the thrombotic risks associated with lipoprotein(a).
Miles LA; Fless GM; Levin EG; Scanu AM; Plow EF
Nature; 1989 May; 339(6222):301-3. PubMed ID: 2542796
[TBL] [Abstract][Full Text] [Related]
2. Interaction of Lp(a) with plasminogen binding sites on cells.
Miles LA; Fless GM; Scanu AM; Baynham P; Sebald MT; Skocir P; Curtiss LK; Levin EG; Hoover-Plow JL; Plow EF
Thromb Haemost; 1995 Mar; 73(3):458-65. PubMed ID: 7667829
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of Apo(a) kringle IV-10 and plasminogen kringles on the interactions of lipoprotein(a) with regulatory molecules.
Xue S; Green MA; LoGrasso PV; Boettcher BR; Madison EL; Curtiss LK; Miles LA
Thromb Haemost; 1999 Mar; 81(3):428-35. PubMed ID: 10102473
[TBL] [Abstract][Full Text] [Related]
4. [Lipoprotein(a): characteristics of a special lipoprotein and its potential clinical significance].
Armstrong VW
Ther Umsch; 1990 Jun; 47(6):475-81. PubMed ID: 2142832
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein(a). A potential bridge between the fields of atherosclerosis and thrombosis.
Scanu AM
Arch Pathol Lab Med; 1988 Oct; 112(10):1045-7. PubMed ID: 2972266
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein(a): a genetically determined lipoprotein containing a glycoprotein of the plasminogen family.
Scanu AM
Semin Thromb Hemost; 1988 Jul; 14(3):266-70. PubMed ID: 2972066
[TBL] [Abstract][Full Text] [Related]
7. Lp(a): an interloper into the fibrinolytic system?
Miles LA; Plow EF
Thromb Haemost; 1990 Jun; 63(3):331-5. PubMed ID: 2169655
[No Abstract] [Full Text] [Related]
8. Absence of inhibition by lipoprotein (a) inhibition of tPA induced thrombolysis in a patient's plasma milieu.
Lu H; Bruckert J; Soria J; Li H; de Gennes JL; Legrand A; Peynet J; Soria C
Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):513-6. PubMed ID: 1966796
[TBL] [Abstract][Full Text] [Related]
9. Effect of lipoprotein(a) and LDL on plasminogen binding to extracellular matrix and on matrix-dependent plasminogen activation by tissue plasminogen activator.
Pekelharing HL; Kleinveld HA; Duif PF; Bouma BN; van Rijn HJ
Thromb Haemost; 1996 Mar; 75(3):497-502. PubMed ID: 8701415
[TBL] [Abstract][Full Text] [Related]
10. Physiological and clinical importance of lipoprotein(a).
Romics L; Karádi I; Császár A; Kostner GM
Tokai J Exp Clin Med; 1990 May; 15(2-3):149-54. PubMed ID: 2151833
[TBL] [Abstract][Full Text] [Related]
11. [Lipoprotein (a). An additional marker of atherosclerosis].
Mezdour H; Parra HJ; Aguie-Aguie G; Fruchart JC
Ann Biol Clin (Paris); 1990; 48(3):139-53. PubMed ID: 2141241
[TBL] [Abstract][Full Text] [Related]
12. [Lipoprotein-mediated functional changes in the fibrinolytic system in the genesis of atherosclerosis].
García Frade LJ; García Avello A
Sangre (Barc); 1991 Feb; 36(1):25-8. PubMed ID: 1649496
[No Abstract] [Full Text] [Related]
13. [Lipoprotein(a) as an athero-thrombotic risk factor: epidemiologic evidence and possible pathogenetic mechanisms].
Lenzi S; Scanu A; De Caterina R
G Ital Cardiol; 1996 Oct; 26(10):1203-25. PubMed ID: 9005165
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models.
Boffa MB; Marcovina SM; Koschinsky ML
Clin Biochem; 2004 May; 37(5):333-43. PubMed ID: 15087247
[TBL] [Abstract][Full Text] [Related]
15. [Molecular patho-biochemistry and genetic diagnosis for plasminogen-apolipoprotein (a) gene family related to atherosclerosis and thrombosis].
Ichinose A
Rinsho Byori; 1998 Dec; 46(12):1210-8. PubMed ID: 9916506
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of u-PA and u-PAR on monocytes by LDL and Lp(a) lipoproteins--consequences for plasmin generation and monocyte adhesion.
Ganné F; Vasse M; Beaudeux JL; Peynet J; François A; Paysant J; Lenormand B; Collet JP; Vannier JP; Soria J; Soria C
Thromb Haemost; 1999 Apr; 81(4):594-600. PubMed ID: 10235446
[TBL] [Abstract][Full Text] [Related]
17. Further characterization of the cellular plasminogen binding site: evidence that plasminogen 2 and lipoprotein a compete for the same site.
Gonzalez-Gronow M; Edelberg JM; Pizzo SV
Biochemistry; 1989 Mar; 28(6):2374-7. PubMed ID: 2543441
[TBL] [Abstract][Full Text] [Related]
18. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
Vines DJ; Lee SW; Dichek DA; Ellis V
J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879
[TBL] [Abstract][Full Text] [Related]
19. The receptor for urokinase-type plasminogen activator of a human keratinocyte line (HaCaT).
Reinartz J; Link J; Todd RF; Kramer MD
Exp Cell Res; 1994 Oct; 214(2):486-98. PubMed ID: 7925643
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein(a) impairs generation of plasmin by fibrin-bound tissue-type plasminogen activator. In vitro studies in a plasma milieu.
Rouy D; Grailhe P; Nigon F; Chapman J; Anglés-Cano E
Arterioscler Thromb; 1991; 11(3):629-38. PubMed ID: 1827591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
